<DOC>
	<DOC>NCT01212874</DOC>
	<brief_summary>This is an investigator initiated, sponsored, open label, prospective randomized controlled trial to be performed in adult patients undergoing scheduled cardiac surgery. Patients will be randomized to esmolol infusion or nitroglycerin infusion for control of hypertension that occurs during cardiac surgery from induction of anesthesia to initiation of cardiopulmonary bypass (CPB).</brief_summary>
	<brief_title>Esmolol or Nitroglycerin Infusion for Blood Pressure Control Prior to Cardiopulmonary Bypass (CPB) in Cardiac Surgery</brief_title>
	<detailed_description />
	<mesh_term>Nitroglycerin</mesh_term>
	<mesh_term>Esmolol</mesh_term>
	<criteria>adult patients scheduled for cardiac surgery at LLUMC University Hospital will be eligible for participation in this study. 1. severe LV (left ventricle)dysfunction (EF &lt; 35%). 2. emergency procedures. 3. procedures with combined carotid artery surgery. 4. patients at high risk for stroke. 5. hemodynamically significant dysrhythmias. 6. preexisting atrial fibrillation or high degree AV (atrioventricular block). 7. pacemaker dependency. 8. known sensitivity to beta blockers. 9. patient refusal.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>